Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons
Chuyu Chen, Qianzi He, Giulia Tombesi, et al.
Journal of Parkinson'S Disease
|
May 23, 2022
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
Belén Fernández, Vinita G Chittoor-Vinod, Jillian H Kluss, et al.
Molecular Neurodegeneration
|
January 24, 2018
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
Jesús Madero-Pérez, Elena Fdez, Belén Fernández, et al.
NPJ Parkinson'S Disease
|
January 9, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
Science Translational Medicine
|
August 30, 2023
A blood-based marker of mitochondrial DNA damage in Parkinson's disease
Rui Qi, Esther Sammler, Claudia P Gonzalez-Hunt, et al.
Autophagy
|
September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Autophagy
|
February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>
Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons
Chuyu Chen, Qianzi He, Giulia Tombesi, et al.
Journal of Parkinson'S Disease
|
May 23, 2022
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
Belén Fernández, Vinita G Chittoor-Vinod, Jillian H Kluss, et al.
Molecular Neurodegeneration
|
January 24, 2018
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation
Jesús Madero-Pérez, Elena Fdez, Belén Fernández, et al.
NPJ Parkinson'S Disease
|
January 9, 2024
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, et al.
Science Translational Medicine
|
August 30, 2023
A blood-based marker of mitochondrial DNA damage in Parkinson's disease
Rui Qi, Esther Sammler, Claudia P Gonzalez-Hunt, et al.
Autophagy
|
September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Autophagy
|
February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>
Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Page
of 6